Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Covid19-Sources
A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections - 2022.01.10.475725v1.full.pdf
Anthony J Leonardi, PhD, MS on Twitter
Empfehlungen zur stationären Therapie von Patienten mit COVID-19 - Living Guideline
The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment - 2022.01.08.22268944v1.full.pdf
Covid loses 90% of ability to infect within five minutes in air – study
Effectiveness of BNT162b2 (Pfizer-BioNTech) ...
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
desh-data/README.md at main · corneliusroemer/desh-data
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report - PMC
Studie: COVID-19 könnte Diabetes bei Kindern begünstigen
(1) Denise Dewald, MD 🗽 auf Twitter: "Again, when they tell you that the long-term devastation of Long Covid could not have been foreseen, do not believe them. SARS1 devastated the long-term health of a substantial proportion of survivors. It's a neuroinvasive virus that can damage the brain. https://t.co/lTP6DziBFf https://t.co/TwgH45RfAl" / Twitter
Early Data Hints at Omicron’s Potential Toll Across America
Active epidemiological investigation on SARS-CoV-2 infection caused by Omicron variant (Pango lineage B.1.1.529) in Japan: preliminary report on infectious period
RKI Vitamin D Deutschland
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 ...
(1) Dominique de Quervain auf Twitter: "COVID-19 führt auch nach mildem Verlauf häufig (10% plus) zu anhaltenden neurologischen Störungen wie Gedächtnisproblemen, Fatigue oder Geruchsstörungen. Ein 🧵 aus neurowissenschaftlicher Perspektive. (1/n) #LongCovid #PostCovid" / Twitter
Effectiveness of 3 doses of COVID-19 vaccines against symptomatic COVID-19 and hospitalisation in adults aged 65 years and older
Lung function decline in relation to COVID-19 in the general population: a matched cohort study with pre-pandemic assessment of lung function | The Journal of Infectious Diseases | Oxford Academic
Discordant SARS-CoV-2 PCR and Rapid Antigen Test Results When Infectious: A December 2021 Occupational Case Series
(5) Ian Ricksecker auf Twitter: "PSA: COVID-19 isn’t “just a cold,” isn’t “a respiratory virus,” and “mild” doesn’t mean what you think it does. If you “aren’t scared of COVID”, this thread is for you. (1/🧵) Please R/T if it opens your eyes." / Twitter
Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021
Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France | Adolescent Medicine | JAMA | JAMA Network
COVID-19 vaccine safety updates: Primary series in children and adolescents ages 5–11 and 12–15 years, and booster doses in adolescents ages 16–24 years
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM
(16) Erin C. Sanders, MSN, WHNP-BC (She/Her) auf Twitter: "The fact that #Omicron doesn’t replicate as much in the lung doesn’t make me feel better. Why? #COVID19 was never just a respiratory disease, that’s its primary mode of transmission. I’m increasingly concerned about what this means for vasculature/clot presentation in particular." / Twitter
Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection | Journal of Translational Medicine | Full Text